These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39106668)

  • 21. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
    Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
    Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-specific models of hiPSC-CMs developed by the gradient-based parameter optimization method fitting two different action potential waveforms.
    Zhang Y; Toyoda F; Himeno Y; Noma A; Amano A
    Sci Rep; 2024 Jun; 14(1):13086. PubMed ID: 38849433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
    Bai S; Pei J; Chen K; Zhao Y; Cao H; Tian L; Ma Y; Dong H
    SLAS Discov; 2021 Mar; 26(3):364-372. PubMed ID: 32914673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Electrophysiological identification of human induced pluripotent stem cell-derived cardiomyocytes].
    Zhang HY; Zhang TT; Machuki JO; Wu LJ; Sun H
    Sheng Li Xue Bao; 2018 Jun; 70(3):281-286. PubMed ID: 29926069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological Analysis of hiPSC-Derived Cardiomyocytes Using a Patch-Clamp Technique.
    Yamamoto Y; Hirose S; Wuriyanghai Y; Yoshinaga D; Makiyama T
    Methods Mol Biol; 2021; 2320():121-133. PubMed ID: 34302654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes.
    Davis J; Chouman A; Creech J; Monteiro da Rocha A; Ponce-Balbuena D; Jimenez Vazquez EN; Nichols R; Lozhkin A; Madamanchi NR; Campbell KF; Herron TJ
    JCI Insight; 2021 May; 6(10):. PubMed ID: 33878037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human induced pluripotent stem cell-derived atrial cardiomyocytes recapitulate contribution of the slowly activating delayed rectifier currents IKs to repolarization in the human atrium.
    Sönmez MI; Goldack S; Nurkkala E; Schulz C; Klampe B; Schulze T; Hansen A; Eschenhagen T; Koivumäki J; Christ T
    Europace; 2024 Jun; 26(6):. PubMed ID: 38788213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes.
    Treat JA; Goodrow RJ; Bot CT; Haedo RJ; Cordeiro JM
    Biochem Pharmacol; 2019 Nov; 169():113608. PubMed ID: 31465775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Cell RNA-Sequencing and Optical Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Discordance Between Cardiac Subtype-Associated Gene Expression Patterns and Electrophysiological Phenotypes.
    Biendarra-Tiegs SM; Li X; Ye D; Brandt EB; Ackerman MJ; Nelson TJ
    Stem Cells Dev; 2019 May; 28(10):659-673. PubMed ID: 30892143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1.
    Meijer van Putten RM; Mengarelli I; Guan K; Zegers JG; van Ginneken AC; Verkerk AO; Wilders R
    Front Physiol; 2015; 6():7. PubMed ID: 25691870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-Optical Electrophysiology Refines Populations of In Silico Human iPSC-CMs for Drug Evaluation.
    Paci M; Passini E; Klimas A; Severi S; Hyttinen J; Rodriguez B; Entcheva E
    Biophys J; 2020 May; 118(10):2596-2611. PubMed ID: 32298635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chamber-specific contractile responses of atrial and ventricular hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development.
    Lickiss B; Hunker J; Bhagwan J; Linder P; Thomas U; Lotay H; Broadbent S; Dragicevic E; Stoelzle-Feix S; Turner J; Gossmann M
    J Pharmacol Toxicol Methods; 2024; 128():107529. PubMed ID: 38857637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent Optogenetic Tachypacing of Atrial Engineered Heart Tissue Induces Only Limited Electrical Remodelling.
    Lemoine MD; Lemme M; Ulmer BM; Braren I; Krasemann S; Hansen A; Kirchhof P; Meyer C; Eschenhagen T; Christ T
    J Cardiovasc Pharmacol; 2020 Dec; 77(3):291-299. PubMed ID: 33278190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes.
    Bizy A; Guerrero-Serna G; Hu B; Ponce-Balbuena D; Willis BC; Zarzoso M; Ramirez RJ; Sener MF; Mundada LV; Klos M; Devaney EJ; Vikstrom KL; Herron TJ; Jalife J
    Stem Cell Res; 2013 Nov; 11(3):1335-47. PubMed ID: 24095945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes.
    Li W; Han JL; Entcheva E
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1112-H1122. PubMed ID: 32986966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.
    Yechikov S; Copaciu R; Gluck JM; Deng W; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2016 Nov; 34(11):2670-2680. PubMed ID: 27434649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The assessment of electrophysiological activity in human-induced pluripotent stem cell-derived cardiomyocytes exposed to dimethyl sulfoxide and ethanol by manual patch clamp and multi-electrode array system.
    Hyun SW; Kim BR; Hyun SA; Seo JW
    J Pharmacol Toxicol Methods; 2017 Sep; 87():93-98. PubMed ID: 28377112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes.
    Pölönen RP; Swan H; Aalto-Setälä K
    Mol Biol Rep; 2020 Feb; 47(2):1067-1077. PubMed ID: 31786768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.
    Feaster TK; Casciola M; Narkar A; Blinova K
    Physiol Rep; 2021 Nov; 9(21):e15085. PubMed ID: 34729935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.